Sign Up to like & get
recommendations!
0
Published in 2019 at "Cardiovascular Toxicology"
DOI: 10.1007/s12012-019-09547-4
Abstract: In the present study, we investigated the cardioprotective effects of coenzyme Q10 (Q10) against doxorubicin (DOXO) induced cardiomyopathy. Twenty adult rats were distributed in four experimental groups: group 1 received NaCl 0.9% at 1 ml/day for…
read more here.
Keywords:
heart;
cardioprotective effects;
doxo;
treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Biophysical Journal"
DOI: 10.1016/j.bpj.2018.11.2729
Abstract: | 7 Abstract As a chemotherapeutic agent heavily used since 1969, Doxorubicin’s (Doxo) mission is well known and carried out, in a variety of cancers. Doxo halts cancerous cell replication and causes cancerous cells to…
read more here.
Keywords:
dna;
doxo;
molecule;
binding dna ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Biomaterials science"
DOI: 10.1039/c9bm01644a
Abstract: Combinations of conventional chemotherapeutics with unconventional anticancer agents such as reactive oxygen and nitrogen species may offer treatment benefits for cancer therapies. Here we report a novel polymeric platform combining the delivery of Doxorubicin (DOXO)…
read more here.
Keywords:
polymeric platform;
doxo;
novel polymeric;
nitric oxide ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-16-0832
Abstract: Given the very limited efficacy of doxorubicin (doxo) in soft tissue sarcoma, there is a clear need for more active and less toxic treatments for this family of diseases. However, due to the rarity of…
read more here.
Keywords:
sarcoma;
algp doxo;
doxo;
efficacy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Hypertension"
DOI: 10.1161/hyp.81.suppl_1.p396
Abstract: Objective: Doxorubicin (Doxo) is used as an antiproliferative agent to treat various cancers. However, a significant limitation of Doxo is cardiotoxicity, that can induce heart failure in patients. Mounting evidence indicates that an increased generation…
read more here.
Keywords:
lipid peroxidation;
cardiotoxicity;
rarb2 stimulation;
oxidative stress ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e23057
Abstract: e23057 Background: Empagliflozin (EMPA), a selective inhibitor of the sodium glucose co-transporter 2 (SGLT2), reduces the risk of hospitalization for heart failure or cardiovascular death in type 2 diabetic patients. We aimed to study if…
read more here.
Keywords:
cardioprotective anti;
effects doxorubicin;
doxo;
inflammatory effects ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Current medicinal chemistry"
DOI: 10.2174/0109298673359261250504031207
Abstract: INTRODUCTION Ovarian cancer, a significant contributor to global female mortality and the third most prevalent gynecological cancer in India, poses challenges for conventional treatments like chemotherapy and radiotherapy. METHOD This study explores the effect of…
read more here.
Keywords:
cancer;
chemotherapy;
doxo;
ovarian cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10040862
Abstract: Despite poor response rates and dose-limiting cardiotoxicity, doxorubicin (doxo) remains the standard-of-care for patients with advanced soft tissue sarcoma. We evaluated the efficacy of two tetrapeptidic doxo prodrugs (PhAc-ALGP-Dox or CBR-049 and CBR-050) that are…
read more here.
Keywords:
thop1;
cbr 049;
soft tissue;
tissue sarcoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231911098
Abstract: Doxorubicin (DOXO) remains amongst the most commonly used anti-cancer agents for the treatment of solid tumors, lymphomas, and leukemias. However, its clinical use is hampered by cardiotoxicity, characterized by heart failure and arrhythmias, which may…
read more here.
Keywords:
effect;
cardiac sympathetic;
doxorubicin;
sympathetic neurons ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231911555
Abstract: Several semisynthetic, low-cardiotoxicity doxorubicin (DOXO) conjugated have been extensively described, considering the risk of cytotoxicity loss against resistant tumor cells, which mainly present drug efflux capacity. Doxorubicin 14-[4-(4-phenyl-5-thioxo-5H-[1,2]dithiol-3-yl)]-benzoate (H2S-DOXO) was synthetized and tested for its…
read more here.
Keywords:
h2s doxo;
efficiency;
h2s;
doxo ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232415575
Abstract: Different gold nanosystems covered with DNA and doxorubicin (Doxo) were designed and synthesized for cancer therapy, starting from Au@16-Ph-16 cationic nanoparticles and DNA–Doxo complexes prepared under saturation conditions. For the preparation of stable, biocompatible, and…
read more here.
Keywords:
cell;
liver;
spectroscopy;
gold ... See more keywords